Tuesday December 15, 2020

Mechanistic Science Deep Dives

Workshop A - 10.30 AM

Epigenetic Mechanisms Governing Liver Fibrogenesis Delineating & Utilizing the Complexities of Fibrosis Pathology


Jelena Mann, Professor of Epigenetics, Newcastle University

Derek Mann, Dean of Research and Innovation, Newcastle University 

Workshop B - 1.30 PM

Inflammation & Inflammasome Modulation to Treat NASH & Liver Fibrosis


Ariel Feldstein (Keynote Speaker) Professor & Chief, Pediatric Gastroenterology UC San Diego, Founder Jecure Therapeutics

Davide Povero Senior Research Scientist Department of Biochemistry & Molecular Biology Mayo Clinic 

Gyongyi Szabo Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School 

Models & Imaging:
Where to Start?

Workshop C - 10.30 AM

Getting to Grips with the Non-Invasive Evaluation of NAFLD & NASH: A Crash Course for Imaging to Quantify Fibrosis in NASH


Peter Caravan, Co-Director, Institute for Innovation in Imaging, Massachusetts General Hospital

Hannah Drescher, Postdoctoral Researcher, Massachusetts General Hospital


Workshop D - 1.30 PM

Assessing the Translational Relevance & Robustness of Preclinical Modalities to More Confidently Progress NASH Candidates into the Clinic


Bryan Fuchs, Therapeutic Area Head, GI & Liver Disease Ferring Pharmaceuticals

Chandra Saravanan, Senior Veterinary Pathologist Novartis Institutes for BioMedical Research (NIBR)


Beyond Efficacy

Workshop E - 10.30 AM

Understanding Hepatocellular Carcinoma as an Extension of NASH Cirrhosis


Bin Gao (Keynote Speaker), Chief, Laboratory of Liver Diseases, NIAAA, NIH

Paul Monga (Keynote Speaker) Director Pittsburgh Liver Research Center, University of Pittsburgh, School of Medicine

Yury Popov, Assistant Professor of Medicine, Harvard Medical School